Bacitracin Ointment
bacitracin 500 units/gram · ophthalmic ointment
Antibiotic
Approved uses
Superficial ocular infections involving the conjunctiva and/or cornea caused by bacitracin-susceptible organisms
Apply into the conjunctival sac 1 to 3 times daily.
OFF-LABELNot in the FDA label for this product
Anterior blepharitis (lid margin application)
Remove all scales and crusts, then spread uniformly over the lid margins, 1 to 3 times daily.
Cochrane · class-level only
Blepharitis appears only in this label's Dosage and Administration section; Indications and Usage is limited to conjunctiva and cornea, so lid-margin use sits outside the stated indication. No product-specific trial exists. A Cochrane systematic review and meta-analysis of 34 trials in 2,169 participants with chronic blepharitis found topical antibiotics as a class gave some symptomatic relief and eradicated lid margin bacteria in anterior blepharitis, but its overall conclusion was that there is no strong evidence that any treatment cures chronic blepharitis; that finding is class-level and was not measured on this product.
Contraindications
History of hypersensitivity to bacitracin.
Ophthalmic ointment, 3.5 g (1/8 oz) sterile tamper-evident tube with ophthalmic tip, 500 units bacitracin per gram
Polypeptide antibiotic; blocks cell wall synthesis by inhibiting dephosphorylation of the lipid carrier undecaprenyl pyrophosphate (C55-PP), stalling the carrier cycle that shuttles peptidoglycan subunits across the bacterial membrane. Spectrum per the label is qualitative: strong activity against many gram-positive pathogens including the common streptococci and staphylococci, destructive to certain gram-negative organisms, ineffective against fungi.
Warnings & Precautions
- Deep-seated ocular infections: Do not use in deep-seated ocular infections or in those likely to become systemic.
- Nonsusceptible organism overgrowth: Prolonged use of antibiotic-containing preparations may result in overgrowth of nonsusceptible organisms, particularly fungi; if new infections develop during treatment, institute appropriate antibiotic or chemotherapy.
- Gross contamination of the ointment: Instruct patients to take appropriate measures to avoid gross contamination of the ointment when applying it directly to the infected eye.
Common Side Effects
- Ocular: Local reactions rare; discontinue if one occurs.
- Contact hypersensitivity: Dermatology patch-test surveillance ranks it second only to neomycin among allergens in medication-associated positive reactions (North American Contact Dermatitis Group, 2001 to 2018), so weigh it in periocular dermatitis that worsens on treatment.
Pregnancy: The label has no pregnancy section and does not address use in pregnancy.
Lactation: The label has no nursing mothers section and does not address use during breastfeeding.
The label has no pediatric use section and does not address use in children.